Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine Dosing for NMB Reversal under Sevoflurane vs TIVA
NCT05037006Phase 4Unknown
- Sponsor
- Pontifícia Universidade Católica de São Paulo
- Start
- Oct 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of neostigmine in neuromuscular blockade (NMB), sponsored by Pontifícia Universidade Católica de São Paulo. Status: unknown.
02
Drugs
neostigmine
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT05037006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05037006.